ZLAB Q3 2024 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$102M+47.7% YoY

Gross Profit

$65M63.9% margin

Operating Income

-$68M-66.4% margin

Net Income

-$42M-40.7% margin

EPS (Diluted)

$-4.30

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$57M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$985M

Total Liabilities

$318M

Stockholders' Equity

$668M

Cash & Equivalents

$616M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$69M	+47.7%
Gross Profit	$65M	$44M	+49.4%
Operating Income	-$68M	-$84M	+18.8%
Net Income	-$42M	-$69M	+39.7%